أعرض في EDS

Universal screening for substance use by Peer Support Specialists in the Emergency Department is a pathway to buprenorphine treatment

التفاصيل البيبلوغرافية
العنوان: Universal screening for substance use by Peer Support Specialists in the Emergency Department is a pathway to buprenorphine treatment
المؤلفون: Grayson Bowen, Brenda Pearson, Robyn Jordan, Kate E. Roberts, Alex K Gertner
المصدر: Addictive Behaviors Reports, Vol 14, Iss, Pp 100378-(2021)
Addictive Behaviors Reports
بيانات النشر: Elsevier, 2021.
سنة النشر: 2021
مصطلحات موضوعية: medicine.medical_specialty, Short communication, education, Peer support, Heroin, Social pathology. Social and public welfare. Criminology, medicine, Psychology, Medication for opioid use disorder, Medical prescription, HV1-9960, biology, business.industry, Emergency department, Opioid use disorder, medicine.disease, biology.organism_classification, Buprenorphine, BF1-990, Psychiatry and Mental health, Peer support specialists, Emergency medicine, Cannabis, Brief intervention, business, medicine.drug
الوصف: Highlights • Peer support specialists effectively screen patients for substance use disorder. • Utilizing peer support specialists enhanced feasibility medication initiation. • Emergency room-initiated medication connects patients to treatment.
Introduction Evidence suggests emergency department (ED)-initiated buprenorphine as efficacious in connecting ED patients to Medications for Opioid Use Disorder (MOUD) utilizing peer support specialists (PSS). However, there are no reports of implementation of ED-initiated buprenorphine in practice. Such information is crucial to support the adoption of ED-initiated buprenorphine. Methods In this quality improvement pilot study, a PSS screened ED patients over age 18 with the Tobacco, Alcohol, Prescription medication, and other Substance use – 1 (TAPS-1). The PSS considered the patient a positive screen if the patient met the following criteria: risky weekly alcohol use, illicit drugs, or prescription drugs. For patients who screened positive, the PSS delivered a brief intervention and assessed interest in treatment. An ED clinician assessed patients who screened positive for heroin/opioid use and were interested in treatment for buprenorphine induction. Results From January through June 2019, 1037 patients were screened for risky substance use, and, of these, 238 (23%) screened positive. The distribution of primary substance used was: 51% alcohol, 26% cannabis, 7.5% cocaine, 7.5% heroin, and 3.3% prescription opioids. Of the 23 patients who screened positive for heroin/opioid use and requested treatment, seven were admitted to the hospital. Of the remaining 16 patients, 14 patients wanted buprenorphine treatment, seven were provided buprenorphine in the ED, and four of these attended their intake appointments for community-based MOUD treatment. Conclusion ED-initiated buprenorphine facilitated by a PSS is feasible and requires coordination and planning. Approaches to ED-initiated buprenorphine that screen only for opioid use will miss many patients interested in substance use treatment.1
اللغة: English
تدمد: 2352-8532
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4073dc949a7b0d9ed2769fd43fca3c08
http://www.sciencedirect.com/science/article/pii/S2352853221000419
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....4073dc949a7b0d9ed2769fd43fca3c08
قاعدة البيانات: OpenAIRE
الوصف
تدمد:23528532